)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Optomed
Optomed (OPTOMED) investor relations material
Optomed Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary6 May, 2026
Executive summary
Achieved strongest quarter ever for Aurora AEYE new subscription sales, despite overall weak revenue development and temporary regulatory uncertainty.
Revenue declined 16.7% year-over-year to €3.35 million, mainly due to timing effects and US regulatory uncertainty impacting Devices segment sales.
Devices segment impacted by timing issues and regulatory uncertainty, while software segment margins normalized.
Gross margin improved to 68.7% from 67.0% year-over-year, supported by high-margin AI revenue.
EBITDA loss narrowed slightly to €-701k, with cost discipline offsetting lower revenue.
Financial highlights
Q1 2026 revenue declined 16.7% year-over-year to €3.35 million; gross profit down 14.5%.
EBITDA improved by 4.9% to -€701k, with EBITDA margin at -20.9%.
Net loss narrowed to -€1.1 million from -€1.58 million; EPS improved to -0.05 from -0.08.
Cash flow from operating activities was -€1.43 million, down from €371k in Q1 2025.
Net debt at -€6.43 million, indicating a net cash position.
Outlook and guidance
Expects full-year 2026 revenue growth compared to 2025, supported by Aurora AEYE and Lumo sales; guidance unchanged despite near-term visibility challenges.
Software segment faces a challenging domestic market in Finland; weak Q1 puts pressure on subsequent quarters.
Uncertainty in timing and size of large capital expenditure deals due to market dynamics and geopolitics.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Optomed
- Devices growth and share issue lifted 2025 revenue, but Q4 declined and outlook remains cautious.OPTOMED
Q4 202510 Feb 2026 - Q4 Devices revenue soared 149%, with FDA clearance fueling 2025 growth optimism.OPTOMEDQ4 20243 Dec 2025
- Devices segment drove 183.6% Q3 growth, while software declined and margins improved.OPTOMEDQ3 20256 Nov 2025
- H1 2025 revenue up 15.1% with Devices surging 49.5% and new AI device launched.OPTOMEDQ2 20257 Aug 2025
- Q3 revenue fell 26% as device sales slumped, but liquidity remains strong.OPTOMEDQ3 202413 Jun 2025
- Revenue fell, but cash and FDA clearance boost outlook amid China credit risks.OPTOMEDQ2 202413 Jun 2025
- Devices revenue up 71.5% and positive cash flow signal robust 2025 growth.OPTOMEDQ1 20255 Jun 2025
Next Optomed earnings date
Q2 202614 Aug, 2026
Optomed
Next Optomed earnings date
Q2 202614 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage